Efficacy and safety evaluation of rivaroxaban vs. warfarin among non-valvular atrial fibrillation patients undergoing lower extremity revascularization

INTRODUCTION: The efficacy and safety of antithrombotic strategies remain uncertain in patients with atrial fibrillation undergoing lower-extremity revascularisation. MATERIALS AND METHODS: Between January 2011 and November 2021, 319 patients with atrial fibrillation after lower-extremity revascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Qingyuan, Chen, Cheng, Xu, Jinyan, Xiao, Yu, Bao, Junmin, Yuan, Liangxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489830/
https://www.ncbi.nlm.nih.gov/pubmed/36158839
http://dx.doi.org/10.3389/fcvm.2022.978639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489830/
https://www.ncbi.nlm.nih.gov/pubmed/36158839
http://dx.doi.org/10.3389/fcvm.2022.978639

Ejemplares similares